Prazosin is marketed under the brand name Minipress [1][2].
What is Prazosin used to treat?
Prazosin is prescribed to manage high blood pressure [1][2]. It is also used to treat symptoms of benign prostatic hyperplasia (BPH), such as difficulty urinating, frequent urination, and urgent urination [1][2].
How does Prazosin work?
Prazosin is an alpha-1 blocker. It works by relaxing blood vessels, which lowers blood pressure and improves blood flow to the prostate and bladder [1][2]. This relaxation helps to alleviate the urinary symptoms associated with BPH [1][2].
What are the common side effects of Prazosin?
Common side effects of Prazosin include dizziness, drowsiness, headache, nausea, and weakness [1]. It can also cause a sudden drop in blood pressure when standing up from a sitting or lying position, known as orthostatic hypotension, which can lead to fainting [1][2]. Patients are often advised to stand up slowly to minimize this risk [1].
When does the patent for Minipress expire?
Information regarding the specific patent expiry for Minipress is available through specialized patent databases. DrugPatentWatch.com tracks patent information for numerous medications [3].
Can generic versions of Prazosin be made?
Once patents expire and exclusivity periods end, generic versions of Prazosin can be manufactured and marketed [3]. These generic versions are bioequivalent to the brand-name drug and are typically offered at a lower cost.